• Stephanie B Kiser, Kate Sciacca, Nelia Jain, Richard Leiter, Emanuele Mazzola, Samantha Gelfand, Jonathan Jehle, Rachelle Bernacki, Daniela Lamas, Zara Cooper, and Joshua R Lakin.
• Division of Palliative Care and Geriatric Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA.
• Crit. Care Med. 2022 May 1; 50 (5): 819824819-824.

ObjectivesTo determine the 30- and 90-day outcomes of COVID-19 patients receiving tracheostomy and percutaneous endoscopic gastrostomy (PEG).DesignRetrospective observational study.SettingMultisite, inpatient.PatientsHospitalized COVID-19 patients who received tracheostomy and PEG at four Boston hospitals.InterventionsTracheostomy and PEG placement.Measurements And Main ResultsThe primary outcome was mortality at 30 and 90 days post-procedure. Secondary outcomes included continued device presence, place of residence, complications, and rehospitalizations. Eighty-one COVID-19 patients with tracheostomy and PEG placement were included. At 90 days post-device placement, the mortality rate was 9.9%, 2.7% still had the tracheostomy, 32.9% still had the PEG, and 58.9% were at home.ConclusionsMore than nine-in-10 patients in our population of COVID-19 patients who underwent tracheostomy and PEG were alive 90 days later and most were living at home. This study provides new information regarding the outcomes of this patient population that may serve as a step in guiding clinicians, patients, and families when making decisions regarding these devices.Copyright © 2022 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.

11 keywords...

hide…